Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft
CONCLUSION: Combined treatment with pirfenidone and PD-L1 inhibitor significantly inhibits the progression of bladder cancer in mice possibly by regulating tumor immune microenvironment and inhibiting epithelial-mesenchymal transition of the tumor cells.PMID:38501405 | PMC:PMC10954534 | DOI:10.12122/j.issn.1673-4254.2024.02.02
Source: Journal of Southern Medical University - Category: Universities & Medical Training Authors: S Chen S Zhang W Fan W Sun B Liu J Liu Y Guo Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Epithelial Cancer | Oral Cancer | Universities & Medical Training